nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Active specific immunotherapy with hapten-modified autologous melanoma cell vaccine
|
Sato, Takami |
|
1996 |
43 |
3 |
p. 174-179 |
artikel |
2 |
Carbohydrate antigens as targets for active specific immunotherapy
|
Ragupathi, Govindaswami |
|
1996 |
43 |
3 |
p. 152-157 |
artikel |
3 |
Carcinoembryonic antigen as a target for cancer vaccines
|
Hodge, James W. |
|
1996 |
43 |
3 |
p. 127-134 |
artikel |
4 |
Dendritic cells presenting tumor antigen
|
Shurin, Michael R. |
|
1996 |
43 |
3 |
p. 158-164 |
artikel |
5 |
Gene-modified tumor cells as cellular vaccine
|
Baskar, Sivasubramanian |
|
1996 |
43 |
3 |
p. 165-173 |
artikel |
6 |
Immunogenicity increase of autologous tumor cell vaccines by virus infection and attachment of bispecific antibodies
|
Haas, Claudia |
|
1996 |
43 |
3 |
p. 190-194 |
artikel |
7 |
Making the most of mucin: a novel target for tumor immunotherapy
|
Barratt-Boyes, Simon M. |
|
1996 |
43 |
3 |
p. 142-151 |
artikel |
8 |
Oncogene products represent potential targets of tumor vaccines
|
Tuttle, T. M. |
|
1996 |
43 |
3 |
p. 135-141 |
artikel |
9 |
Preface to the symposium in writing on therapeutic cancer vaccines
|
Finn, O. J. |
|
1996 |
43 |
3 |
p. 125 |
artikel |
10 |
Treatment of malignancy by direct gene transfer of a foreign MHC class I molecule
|
DeBruyne, L. A. |
|
1996 |
43 |
3 |
p. 180-189 |
artikel |